Determination of Posaconazole in Plasma/Serum by High-Performance Liquid Chromatography with Fluorescence Detection

Determination of Posaconazole in Plasma/Serum by High-Performance Liquid Chromatography with Fluorescence Detection

A sensitive high-performance liquid chromatographic (HPLC) method is described for the determination of posaconazole in human plasma/serum. The method is based on a single dilution step by treating the sample with methanol, and followed by the direct injection of the sample into the HPLC system. Pos...

Full description

Bibliographic Details
Main Author:	Peter H. Tang
Format:	Article
Language:	English
Published:	MDPI AG 2017-05-01
Series:	Separations
Subjects:	posaconazole ketoconazole HPLC fluorescence
Online Access:	http://www.mdpi.com/2297-8739/4/2/16

Similar Items

Conazoles
by: Jan Heeres, et al.
Published: (2010-06-01)

UV Spectrophotometric method for determination of posaconazole: comparison to HPLC
by: Andressa S. Bitencourt, et al.
Published: (2015-10-01)

Posaconazole as rescue therapy in African histoplasmosis
by: Daniel Gonçalves, et al.
Published: (2013-02-01)

Posaconazole as rescue therapy in African histoplasmosis
by: Daniel Gonçalves, et al.

Efficacy of combination therapy of amphotericin and posaconazole in treatment of mucormycosis
by: Sridhara S, et al.
Published: (2023-03-01)

Posaconazole-induced Glucocorticoid Deficiency in a Patient with Myelodysplastic syndrome.
by: Antonia Precali, et al.
Published: (2023-01-01)

Ion-pairing liquid chromatographic method determination of ketoconazole and stress degradation in pharmaceutical formulations with fluorescence detection
by: Wisanu Thongchai
Published: (2020-04-01)

Advancing posaconazole quantification analysis with a new reverse-phase HPLC method in its bulk and marketed dosage form [version 2; peer review: 2 approved]
by: Srinivas Hebbar, et al.
Published: (2023-06-01)

Interaction between posaconazole and flucloxacillin in a lung transplant patient: decrease in plasma exposure of posaconazole and possible undertreatment of invasive aspergillosis: case report
by: Saartje Verfaillie, et al.
Published: (2022-03-01)

Pharmacokinetics of Venetoclax Co-Administered with Posaconazole in Patients with Acute Myeloid Leukemia
by: Simona De Gregori, et al.
Published: (2023-06-01)

Posaconazole as single or adjunctive antifungal in mucormycosis of the maxilla: systematic review and meta-analysis
by: Pardiwala Arwa, et al.
Published: (2023-01-01)

Posaconazole: A Review of Drug Interactions with HIV Antiretroviral Agents
by: Mara Poulakos, et al.
Published: (2014-03-01)

High-Performance Liquid Chromatography for Ultra-Simple Determination of Plasma Voriconazole Concentration
by: Takeo Yasu, et al.
Published: (2022-09-01)

Factors associated with subtherapeutic levels of oral posaconazole tablet: a detailed analysis from a tertiary care center in India
by: Parikshit S. Prayag, et al.
Published: (2022-11-01)

Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections
by: Wiederhold NP
Published: (2015-12-01)

Pharmaceutical co-crystals of posaconazole for improvement of physicochemical properties
by: Monika Nijhawan, et al.
Published: (2022-08-01)

Posaconazole‐induced hypertension in children with cystic fibrosis
by: Rachael Marpole, et al.
Published: (2021-09-01)

Evaluation of the role of itraconazole and posaconazole in viral infection as immunomodulatory drugs
by: Falah Hasan Obayes AL-Khikani
Published: (2021-01-01)

Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation
by: Döring Michaela, et al.
Published: (2012-10-01)

Successful Treatment of Recurrent Cutaneous Purpureocillium lilacinum (Paecilomyces lilacinus) Infection with Posaconazole and Surgical Debridement
by: Wei-Yu Chen, et al.
Published: (2019-09-01)

Determination of Tramadol in human plasma by HPLC with fluorescence detection
by: Daniela Baconi, et al.
Published: (2016-04-01)

Itraconazole and posaconazole from antifungal to antiviral drugs
by: Falah Hasan Obayes AL-Khikani
Published: (2022-01-01)

Development and Validation of Analytical Method Using Gas Chromatography with Triple Quadrupole Mass Spectrometry for the Detection of Alkyl Halides as Potential Genotoxic Impurities in Posaconazole
by: Hari Naga Prasada Reddy Chittireddy, et al.
Published: (2023-05-01)

The Impact of Hypromellose on Pharmaceutical Properties of Alginate Microparticles as Novel Drug Carriers for Posaconazole
by: Katarzyna Kruk, et al.
Published: (2023-06-01)

Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center
by: Edward T. Van Matre, et al.
Published: (2019-03-01)

Intravenous posaconazole: key features of clinical pharmacology and practical applications
by: A. V. Veselov, et al.
Published: (2022-04-01)

Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole
by: F. Yuan, et al.
Published: (2021-11-01)

A Novel High-performance Liquid Chromatography Method with Fluorescence Detection for the Quantification of Roflumilast in Tablet Formulations
by: Ulvi MEHDİZADE, et al.
Published: (2021-07-01)

High Performance Liquid Chromatography (HPLC) with Fluorescence Detection for Quantification of Steroids in Clinical, Pharmaceutical, and Environmental Samples: A Review
by: Fatima Hameedat, et al.
Published: (2022-03-01)

New Drug Formulations of Posaconazole: Brief Clinical Pharmacology Review
by: Veselov A.V.
Published: (2016-11-01)

Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study
by: Whitley M. Yi, et al.
Published: (2017-09-01)

Cutaneous alternariosis in a renal transplant patient successfully treated with posaconazole: Case report and literature review
by: Rajinder Bajwa, et al.
Published: (2017-03-01)

Severe Posaconazole-Induced Glucocorticoid Deficiency with Concurrent Pseudohyperaldosteronism: An Unfortunate Two-for-One Special
by: Alejandro Villar-Prados, et al.
Published: (2021-07-01)

A Review of Population Pharmacokinetic Models of Posaconazole
by: Ding Q, et al.
Published: (2022-10-01)

Successful treatment of allergic bronchopulmonary aspergillosis with posaconazole in a child with cystic fibrosis: Case report and review of the literature
by: Nurhayat Yakut, et al.
Published: (2020-01-01)

Formation and Characterisation of Posaconazole Hydrate Form
by: Michail Lykouras, et al.
Published: (2022-12-01)

Tratamiento antifúngico con posaconazol y anfotericina B en paciente con mucormicosis rinosinusal
by: MT Martínez-Lazcano, et al.
Published: (2015-04-01)

Tratamiento antifúngico con posaconazol y anfotericina B en paciente con mucormicosis rinosinusal
by: MT Martínez-Lazcano, et al.
Published: (2015-04-01)

Efficacy of the Benznidazole+Posaconazole combination therapy in parasitemia reduction: An experimental murine model of acute Chagas
by: Luis Eduardo Echeverría, et al.

Development of UPLC-MS/MS Method for Studying the Pharmacokinetic Interaction Between Dasatinib and Posaconazole in Rats
by: Yang S, et al.
Published: (2021-05-01)